Comparative in vitro activities of five quinolone antibiotics, including gemifloxacin, against clinical isolates

Clinical Microbiology and Infection

Volumn 7, Issue 9, 2001, Pages 499-503

  Gonullu N ^a   Aktas Z ^b   Salcioglu M ^b   Bal, C ^b   Ang O ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Fluoroquinolones; Gemifloxacin; MIC

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; GEMIFLOXACIN; LEVOFLOXACIN; METICILLIN; NORFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ACINETOBACTER; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG ACTIVITY; ENTEROBACTER; ENTEROCOCCUS; ESCHERICHIA COLI; HAEMOPHILUS INFLUENZAE; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

ACINETOBACTER; BACTERIA (MICROORGANISMS); ENTEROBACTER; ENTEROCOCCUS; ESCHERICHIA COLI; HAEMOPHILUS; HAEMOPHILUS INFLUENZAE; KLEBSIELLA; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORAXELLA CATARRHALIS; PSEUDOMONAS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0035467631     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1198-743X.2001.00297.x     Document Type: Article

References (17)

1. Performance standards for antimicrobial susceptibility testing
2. The in-vitro activity and tentative breakpoint of gemifloxacin, a new fluoroquinolone
3. The fluoroquinolone antibacterials: Past, present and future perspectives
4. In vitro potency of moxifloxacin, clinafloxacin and sitafloxacin against 248 genetically defined clinical isolates of Staphylococcus aureus
5. Comparative activities of clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, ofloxacin, sparfloxacin, and trovafloxacin and nonquinolones linezolid, quinupristin-dalfopristin, gentamicin, and isolates of ciprofloxacin-resistant and -susceptible Staphylococcus aureus strains
6. In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacin
7. A surveillance study of antimicrobial resistance of gram-negative bacteria isolated from intensive care units in eight hospitals in Turkey
8. Comparative in vitro activities of ciprofloxacin, clinafloxacin, gatifloxacin, levofloxacin, moxifloxacin, and trovafloxacin against Klebsiella pneumoniae, Klebsiella oxytoca, Enterobacter cloacae and isolates with alterations in gyrA and ParC proteins
9. A comparative in vitro surveillance study of gemifloxacin activities against 2632 recent Streptococcus pneumoniae isolates from across Europe, North America, and South America
10. Activities of clinafloxacin, gatifloxacin, gemifloxacin, and trovafloxacin against recent clinical isolates of levofloxacin-resistant Streptococcus pneumoniae
11. Activity of moxifloxacin against pathogens with decreased susceptibility to ciprofloxacin
12. In vitro development of resistance to five quinolones and amoxicillin-clavulanate in Streptococcus pneumoniae
13. Penicillin resistance in Streptococcus pneumoniae in Turkey
14. Penicillin resistance in Streptococcus pneumoniae in Istanbul, Turkey
15. Trends in antimicrobial resistance of Streptococcus pneumoniae in children in a Turkish hospital
16. Antimicrobial resistance of clinical isolates of Streptoccocus pneumoniae in Istanbul